Quantum-Si
Press Releases

Quantum-Si’s New Preprint Showcases Advances in Protein Variant Detection using ProteoVue™ Software with Next-Generation Protein Sequencing™

Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Quantum-Si Expands International Distribution Network

Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™

Quantum-Si Introduces Protein Barcoding Kit for Multiplexed Protein Screening

Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event

Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™ Technology

Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA

Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform

Quantum-Si and Planet Innovation to Partner on Proteus™

Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Quantum-Si Honored with Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Next-Generation Protein Sequencing™

Quantum-Si Reports Third Quarter 2024 Financial Results

University of Virginia Researchers Publish New Study on Tropomyosin Proteoforms Showcasing Quantum-Si’s Next-Gen Protein Sequencer™ Platinum®

Quantum-Si to Participate in Upcoming Investment Conferences

Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024

Quantum-Si to Present at the 2024 American Society of Human Genetics Annual Meeting

Quantum-Si to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024

Northwestern Proteomics Center of Excellence Partners with Quantum-Si for Webinar on Advancing Proteoform Analysis with Top-Down Mass Spectrometry and Single-Molecule Sequencing

Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024

Liberate Bio Integrates Quantum-Si’s Next-Generation Protein Sequencing™ Platform to Enhance Gene Therapy Development

Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider

Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Quantum-Si Reports Second Quarter 2024 Financial Results

Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference

Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024

Quantum-Si Announces Presentation on the Use of Next-Generation Protein Sequencing™ to Detect Disease-Relevant Proteoforms at the Festival of Genomics and Biodata

Quantum-Si Announces Presentations at ASMS and ESHG

Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors

Quantum-Si Reports First Quarter 2024 Financial Results

Quantum-Si Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time

Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024

Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors

Quantum-Si and Researchers to Highlight the Power of Next-Generation Protein Sequencing™ on Platinum® at US HUPO Conference

Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results

Renowned Scientist Christopher Mason, Ph.D. and Quantum-Si Collaborate for Exclusive GenomeWeb Webinar

Quantum-Si to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing™ Platform

Quantum-Si Introduces World’s First Next-Generation Protein Sequencer™ in Japan with Addition of New Distributor

Quantum-Si Expands Global Reach with Addition of New Distributor

Quantum-Si Adds Distributor ELTA 90 as Demand for Platinum™ Grows

Quantum-Si Reports Third Quarter 2023 Financial Results

Quantum-Si Honored as Proteomics Company of the Year by the BioTech Breakthrough Awards

Quantum-Si to Participate at Two Upcoming Investor Conferences

Quantum-Si Presents its Vision to Transform Genomics and Proteomics Research at ASHG 2023

Quantum-Si to Report Third Quarter 2023 Financial Results on November 9, 2023

Quantum-Si Hosts Webinar on Advances in Protein Identification and Characterization

Quantum-Si to Present at The Festival of Genomics & Biodata 2023 in Boston, Massachusetts

Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors

Quantum-Si’s Platinum™ Next-Generation Protein Sequencing Instrument Wins Honorable Mention in Fast Company’s 2023 Innovation by Design Awards

Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quantum-Si Reports Second Quarter 2023 Financial Results

Quantum-Si to Participate in the Canaccord Genuity 43rd Annual Growth Conference

Quantum-Si to Report Second Quarter 2023 Financial Results on August 7, 2023

Quantum-Si Announces the Appointment of Industry Veteran Johan Denecke as Senior Vice President of Operations

Quantum-Si Debuts New Headquarters in Branford, Connecticut

Quantum-Si to Participate in the Jefferies Healthcare Conference

Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to its Board of Directors

Scott Mendel Elected to Quantum-Si Board of Directors

Quantum-Si Reports First Quarter 2023 Financial Results

Quantum-Si Announces the Appointment of Jeff Keyes as Chief Financial Officer

Quantum-Si Bolsters Executive Leadership Team with Four Key Appointments

Quantum-Si to Report First Quarter 2023 Financial Results on May 11, 2023

Quantum-Si To Present Poster on Single-Molecule Method for Detection of Arginine Post-Translational Modifications at the AACR Annual Meeting 2023

Quantum-Si to Participate in B. Riley Securities’ Life Sciences Tools Conference – Proteomics Setting the Blueprint for Innovative Drug Creation, Virtual Conference

Quantum-Si Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Quantum-Si to Participate in the 43rd Annual Cowen Health Care Conference

Quantum-Si to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

Quantum-Si and Aviva Systems Biology Partner to Co-Develop Sample Preparation Kits for Protein Sequencing

Quantum-Si and Biovista Partner to Provide AI-Driven Deep Proteomics Insights from the Platinum™ Next-Generation Protein Sequence Platform Output

Quantum-Si Begins Commercial Shipments of the PlatinumTM Protein Sequencing System and Provides Business Updates at the 41st Annual J.P. Morgan Healthcare Conference

Quantum-Si to Participate in the 41st Annual J.P. Morgan Healthcare Conference

Quantum-Si Announces Commercial Availability of PlatinumTM, the World’s First Next-Generation Single-Molecule Protein Sequencing Platform

Quantum-Si Joins Human Proteome Organization (HUPO) Industrial Advisory Board

Quantum-Si Reports Third Quarter 2022 Financial Results

Quantum-Si to Participate in the 16th Annual Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Quantum-Si to Report Third Quarter 2022 Financial Results on November 7, 2022

Quantum-Si’s Next-Generation Single-Molecule Protein Sequencing Technology Published in Science, Signaling New Era of Life Science and Biomedical Research

Quantum-Si Appoints Jeff Hawkins as Chief Executive Officer

Quantum-Si to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Quantum-Si Reports Second Quarter 2022 Financial Results

Quantum-Si to Participate at Two Upcoming Investor Conferences

Quantum-Si to Report Second Quarter 2022 Financial Results on August 8, 2022

Quantum-Si Set to Join the Russell 2000® Index

Quantum-Si Appoints Vikram Bajaj, Ph.D., to Board of Directors

Quantum-Si Highlights Technology Advancements at the VIB Next-Generation Protein Analysis and Detection Conference

Quantum-Si to Present at the 2022 Jefferies Healthcare Conference

Quantum-Si to Present Research and Development Updates at the VIB Next-Generation Protein Analysis and Detection Conference

Quantum-Si to Present at the 2022 UBS Global Healthcare Conference

Quantum-Si Reports First Quarter 2022 Financial Results

Quantum-Si Appoints Patrick Schneider as President and Chief Operating Officer

Quantum-Si to Report First Quarter 2022 Financial Results on May 9, 2022

Quantum-Si to Present at the B. Riley Securities’ Disruptive Biotech Enabling Technologies Virtual Mini Conference

Quantum-Si Reports Fourth Quarter and Fiscal Year 2021 Financial Results

Quantum-Si to Present at the 42nd Annual Cowen Health Care Conference

Quantum-Si Announces Dr. Jonathan Rothberg as Interim CEO

Quantum-Si to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022

Quantum-Si Provides Business Updates at the 40th Annual J.P. Morgan Healthcare Conference

Quantum-Si Signs Lease for New Headquarters in New Haven

Quantum-Si to Present at the 40th Annual J.P. Morgan Healthcare Conference

Quantum-Si Added to the Nasdaq Biotechnology Index

Quantum-Si Reports Third Quarter 2021 Financial Results

Quantum-Si Acquires Majelac Technologies to Strengthen Chip Supply Chain

Quantum-Si to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

Quantum-Si to Report Third Quarter 2021 Financial Results on November 11, 2021

Quantum-Si Announces Expansion of Early Access Program for the Platinum™ Single Molecule Protein Sequencing Platform

Quantum-Si Incorporated to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

Quantum-Si Reports Second Quarter 2021 Financial Results

Quantum-Si to Report Second Quarter 2021 Financial Results on August 16, 2021

Quantum-Si to Report Second Quarter 2021 Financial Results on August 12, 2021

Quantum-Si Signs Lease for Product Development and Operations Facility in San Diego Biotechnology Hub

Quantum-Si, Revolutionizing Proteomics, Closes Business Combination and Will Begin Trading Under the Ticker “QSI” on the Nasdaq Stock Exchange

Quantum-Si and HighCape Capital Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination

Quantum-Si Strengthens Board of Directors with Two Key Appointments

Quantum-Si Appoints Dr. Michael Mina as Chief Medical Advisor

Quantum-Si Announces Appointment of Claudia Napal Drayton as Chief Financial Officer

Quantum-Si, a Pioneer in Semiconductor Chip-Based Proteomics, to Combine with HighCape Capital Acquisition Corp.